Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

34.21
Delayed Data
As of Feb 12
 +0.09 / +0.26%
Today’s Change
30.30
Today|||52-Week Range
46.24
-20.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues180.0M189.9M183.5M193.3M
 
 
 
 
 
Cost of Goods Sold29.9M30.9M29.7M33.8M
 
 
 
 
 
Depreciation And Amortization6.4M6.6M6.8M6.8M
 
 
 
 
 
 
Operating ExpensesGross Income143.7M152.4M147.0M152.7M
 
 
 
 
 
General Expenses108.0M116.2M103.7M107.5M
 
 
 
 
 
Research And Development16.7M18.7M17.2M16.7M
 
 
 
 
 
Total Operating Expenses144.2M153.7M140.2M148.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income35.7M36.2M43.3M45.2M
 
 
 
 
 
Other Expenses-298.0K-800.0K100.0K-300.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.6M35.5M43.5M45.0M
 
 
 
 
 
Income Taxes-14.1M-16.8M-16.9M-14.7M
 
 
 
 
 
Net Income21.5M18.7M26.6M30.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.7M69.4M68.7M70.5M
 
 
 
 
 
Shares To Calculate EPS Diluted73.9M72.4M72.1M73.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.29$0.26$0.37$0.41
 
 
 
 
 
EPS Diluted$0.29$0.26$0.37$0.41